Induced Abortion Provision Among a National Sample of Obstetrician-Gynecologists
- PMID: 30741798
- DOI: 10.1097/AOG.0000000000003110
Induced Abortion Provision Among a National Sample of Obstetrician-Gynecologists
Abstract
Objective: To estimate the proportion of obstetrician-gynecologists (ob-gyns) who provided induced abortion in the prior year, disaggregated by surgical and medication methods, and document barriers to provision of medication abortion.
Methods: In 2016-2017, we conducted a cross-sectional survey of a national sample of American College of Obstetricians and Gynecologists Fellows and Junior Fellows who were part of the Collaborative Ambulatory Research Network. We sent the survey by email, and mailed nonresponders paper surveys. We performed descriptive statistics, χ tests, and logistic regression analyses.
Results: Sixty-seven percent (655/980) of Collaborative Ambulatory Research Network members responded. Ninety-nine percent reported seeing patients of reproductive age, and 72% reported having a patient in the prior year who needed or wanted an abortion. Among those seeing patients of reproductive age, 23.8% (95% CI 20.5%-27.4%) reported performing an induced abortion in the prior year; 10.4% provided surgical and medication abortion, 9.4% surgical only, and 4.0% medication only. In multivariable analysis, physicians practicing in the Midwest (adjusted odds ratio [AOR] 0.31, 95% CI 0.16-0.60) or South (AOR 0.22, 95% CI 0.11-0.42) had lower odds of provision compared with those practicing in the Northeast, whereas those practicing in an urban inner city (AOR 2.71, 95% CI 1.31-5.60) or urban non-inner-city area (AOR 2.89, 95% CI 1.48-5.64 vs midsize towns, rural areas, or military settings) had higher odds of provision. The most common reasons for not providing medication abortion were personal beliefs (34%) and practice restrictions (19%). Among those not providing medication abortion, 28% said they would if they could write a prescription for mifepristone.
Conclusion: Compared with the previous national survey in 2008-2009, abortion provision may be increasing among practicing ob-gyns, although important geographic disparities persist. Few provide medication abortion, but uptake might increase if mifepristone could be prescribed.
Similar articles
-
Estimating abortion provision and abortion referrals among United States obstetrician-gynecologists in private practice.Contraception. 2018 Apr;97(4):297-302. doi: 10.1016/j.contraception.2017.11.004. Epub 2017 Nov 21. Contraception. 2018. PMID: 29174883 Free PMC article.
-
Obstetrician-gynecologist willingness to provide medication abortion with removal of the in-person dispensing requirement for mifepristone.Contraception. 2021 Jul;104(1):73-76. doi: 10.1016/j.contraception.2021.03.026. Epub 2021 Apr 1. Contraception. 2021. PMID: 33811840
-
Abortion Referral Practices among a National Sample of Obstetrician-Gynecologists.Womens Health Issues. 2020 Nov-Dec;30(6):446-452. doi: 10.1016/j.whi.2020.08.002. Epub 2020 Sep 19. Womens Health Issues. 2020. PMID: 32962875
-
Sex differences among obstetrician-gynecologists: a review of survey studies.Obstet Gynecol Surv. 2013 Mar;68(3):235-53. doi: 10.1097/OGX.0b013e318286f0aa. Obstet Gynecol Surv. 2013. PMID: 23945840 Review.
-
Elective abortion: Clinical practice guidelines from the French College of Gynecologists and Obstetricians (CNGOF).Eur J Obstet Gynecol Reprod Biol. 2018 Mar;222:95-101. doi: 10.1016/j.ejogrb.2018.01.017. Epub 2018 Jan 31. Eur J Obstet Gynecol Reprod Biol. 2018. PMID: 29408754 Review.
Cited by
-
Management of early pregnancy loss by reproductive endocrinologists: does access to mifepristone matter?F S Rep. 2024 May 22;5(3):252-258. doi: 10.1016/j.xfre.2024.05.005. eCollection 2024 Sep. F S Rep. 2024. PMID: 39381661 Free PMC article.
-
Mail-Order Pharmacy Dispensing of Mifepristone for Medication Abortion After In-Person Screening.JAMA Intern Med. 2024 Aug 1;184(8):873-881. doi: 10.1001/jamainternmed.2024.1476. JAMA Intern Med. 2024. PMID: 38739404 Free PMC article.
-
Breaking the silence in the primary care office: patients' attitudes toward discussing abortion during contraceptive counseling.Contracept X. 2020 Jun 16;2:100029. doi: 10.1016/j.conx.2020.100029. eCollection 2020. Contracept X. 2020. PMID: 32671336 Free PMC article.
-
Estimating abortion provision and abortion referrals among United States obstetrician-gynecologists in private practice.Contraception. 2018 Apr;97(4):297-302. doi: 10.1016/j.contraception.2017.11.004. Epub 2017 Nov 21. Contraception. 2018. PMID: 29174883 Free PMC article.
References
-
- National Academies of Sciences, Engineering, and Medicine. The safety and quality of abortion care in the United States. Washington, DC: The National Academies Press; 2018.
-
- Stulberg DB, Dude AM, Dahlquist I, Curlin FA. Abortion provision among practicing obstetrician–gynecologists. Obstet Gynecol 2011;118:609–14.
-
- Jones RK, Jerman J. Abortion incidence and service availability in the United States, 2014. Perspect Sex Reprod Health 2017;49:17–27.
-
- Finer LB, Wei J. Effect of mifepristone on abortion access in the United States. Obstet Gynecol 2009;114:623–30.
-
- Leddy MA, Lawrence H, Schulkin J. Obstetrician-gynecologists and women's mental health: findings of the Collaborative Ambulatory Research Network 2005–2009. Obstet Gynecol Surv 2011;66:316–23.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
